Alumnus Greg Galvin, the 2014 Cornell Entrepreneur of the Year and founder and CEO of Rheonix, is ramping up production of an automated, same-day test for the virus that causes COVID-19.
A highly innovative method using the latest technology opens myriad new avenues for research, for understanding the biology behind COVID-19, and for identifying new treatments that target protein binding sites.
Black and Hispanic patients were more likely than white patients to develop a wide array of lasting symptoms and conditions after a COVID-19 diagnosis, according to a new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.
The university is hosting the “Cornell COVID-19 Service of Remembrance,” a virtual event that provides community members an opportunity to mourn losses, Monday, April 19, from noon to 12:45 p.m.
Following Gov. Cuomo’s new coronavirus restrictions on schools, businesses and religious gatherings, Orthodox Jewish leaders have voiced criticism that they are being singled out for the new surge of COVID-19 cases. Jonathan Boyarin, professor of modern Jewish studies and an expert on Jewish experience and culture, is available for interviews.
Dr. David Feldshuh, professor in the Department of Performing and Media Arts and a physician, is continuing his work at Cayuga Medical Center’s Urgent Care amid the coronavirus pandemic.
Food industry professionals can learn how the novel coronavirus might affect their workers and their consumers, thanks to a series of virtual office hours held by staff at the Institute for Food Safety at Cornell.
The proliferation of medical misinformation on social media and the human experience of social distancing are among the pandemic-related topics to receive rapid response grants from the Cornell Atkinson Center for Sustainability.
